BioLife Solutions, Inc. (BLFS)Healthcare | Medical Instruments & Supplies | Bothell, United States | NasdaqCM
21.50 USD
+0.65
(3.118%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 21.50 Short-term: ★★★☆☆ | Long-term: ★★★☆☆ | Dividends: ★★☆☆☆ |
Hot Take | April 18, 2026, 10:32 p.m. EDT
Despite a 'Strong Buy' analyst consensus and massive revenue growth (63.9%), BLFS is currently a 'cautiously defensive' hold rather than a momentum play. The extreme bearish skew in options pricing (high put IV) combined with negative earnings growth (-13.9%) and -11% EPS growth creates a sharp disconnect between long-term narrative and near-term technicals. While fundamentals support a multi-year rebuild, the short-term window is capped by the 'sell the news' reaction and the risk of testing the 17.5/18.0 support floor, making deep OTM puts the more attractive speculative vehicle over long calls. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.186140 |
| MSTL | 0.190409 |
| AutoTheta | 0.194769 |
| AutoARIMA | 0.238153 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 48% |
| H-stat | 5.19 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.108 |
| Excess Kurtosis | -1.53 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 4.812 |
| Revenue per Share | 2.015 |
| Market Cap | 1,038,449,984 |
| Forward P/E | 74.14 |
| Beta | 2.00 |
| Profit Margins | -4.78% |
| Website | https://www.biolifesolutions.com |
As of April 18, 2026, 10:32 p.m. EDT: Options data reveals a defensive contrarian play rather than a strong directional bet. For the April 17 expiry, ATM implied volatility for Puts (7.18%) is roughly 3x that of Calls (2.41%), indicating the market prices in significantly higher downside relief than upside potential for the next week. Despite recent price rallies, significant Open Interest (OI) is concentrated in deep OTM puts (strikes 17.5 and 20.0), while call OI is clustered at resistance levels (35, 40) with minimal activity at nearer strikes. This structure suggests investors are hedging against a potential pullback (likely from recent earnings 'sell the news' or resistance at 22-25) rather than betting on immediate continuation of the recent upward trend.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.016548514 |
| Address1 | 3,303 Monte Villa Parkway |
| Address2 | Suite 310 |
| All Time High | 1,382.5 |
| All Time Low | 0.14 |
| Ask | 27.57 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 345,520 |
| Average Daily Volume3 Month | 425,631 |
| Average Volume | 425,631 |
| Average Volume10Days | 345,520 |
| Beta | 1.996 |
| Bid | 15.43 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 7.716 |
| City | Bothell |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 21.5 |
| Current Ratio | 5.943 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 21.77 |
| Day Low | 21.21 |
| Debt To Equity | 4.812 |
| Display Name | BioLife |
| Earnings Call Timestamp End | 1,772,141,400 |
| Earnings Call Timestamp Start | 1,772,141,400 |
| Earnings Growth | -0.139 |
| Earnings Quarterly Growth | -0.112 |
| Earnings Timestamp | 1,772,139,600 |
| Earnings Timestamp End | 1,778,184,000 |
| Earnings Timestamp Start | 1,778,184,000 |
| Ebitda | 3,606,000 |
| Ebitda Margins | 0.03748 |
| Enterprise To Ebitda | 268.281 |
| Enterprise To Revenue | 10.055 |
| Enterprise Value | 967,420,032 |
| Eps Current Year | 0.16667 |
| Eps Forward | 0.29 |
| Eps Trailing Twelve Months | -0.25 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 425 402 1433 |
| Fifty Day Average | 20.6256 |
| Fifty Day Average Change | 0.8743992 |
| Fifty Day Average Change Percent | 0.042393878 |
| Fifty Two Week Change Percent | 1.6548514 |
| Fifty Two Week High | 29.62 |
| Fifty Two Week High Change | -8.120001 |
| Fifty Two Week High Change Percent | -0.2741391 |
| Fifty Two Week Low | 17.86 |
| Fifty Two Week Low Change | 3.6399994 |
| Fifty Two Week Low Change Percent | 0.20380735 |
| Fifty Two Week Range | 17.86 - 29.62 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 627,748,200,000 |
| Float Shares | 40,631,409 |
| Forward Eps | 0.29 |
| Forward P E | 74.13793 |
| Free Cashflow | 12,438,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 155 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.64562 |
| Gross Profits | 62,118,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02609 |
| Held Percent Institutions | 1.06423 |
| Implied Shares Outstanding | 48,300,000 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,390,953,600 |
| Last Split Factor | 1:14 |
| Long Business Summary | BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington. |
| Long Name | BioLife Solutions, Inc. |
| Market | us_market |
| Market Cap | 1,038,449,984 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_265126 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -12,130,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,038,208,500 |
| Number Of Analyst Opinions | 10 |
| Open | 21.42 |
| Operating Cashflow | 20,115,000 |
| Operating Margins | -0.0032300001 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 15.09 |
| Phone | 425 402 1400 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 21.5 |
| Post Market Time | 1,776,456,604 |
| Previous Close | 20.85 |
| Price Eps Current Year | 128.99742 |
| Price Hint | 2 |
| Price To Book | 2.7864177 |
| Price To Sales Trailing12 Months | 10.793128 |
| Profit Margins | -0.04776 |
| Quick Ratio | 4.216 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.1 |
| Region | US |
| Regular Market Change | 0.65 |
| Regular Market Change Percent | 3.1175 |
| Regular Market Day High | 21.77 |
| Regular Market Day Low | 21.21 |
| Regular Market Day Range | 21.21 - 21.77 |
| Regular Market Open | 21.42 |
| Regular Market Previous Close | 20.85 |
| Regular Market Price | 21.5 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 287,005 |
| Return On Assets | -0.00168 |
| Return On Equity | -0.03366 |
| Revenue Growth | 0.639 |
| Revenue Per Share | 2.015 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 48,300,000 |
| Shares Percent Shares Out | 0.074499995 |
| Shares Short | 3,599,500 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,996,816 |
| Short Name | BioLife Solutions, Inc. |
| Short Percent Of Float | 0.105100006 |
| Short Ratio | 7.4 |
| Source Interval | 15 |
| State | WA |
| Symbol | BLFS |
| Target High Price | 34.0 |
| Target Low Price | 30.0 |
| Target Mean Price | 32.4 |
| Target Median Price | 32.5 |
| Total Cash | 88,927,000 |
| Total Cash Per Share | 1.841 |
| Total Debt | 17,897,000 |
| Total Revenue | 96,214,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.25 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 23.80285 |
| Two Hundred Day Average Change | -2.3028507 |
| Two Hundred Day Average Change Percent | -0.09674685 |
| Type Disp | Equity |
| Volume | 287,005 |
| Website | https://www.biolifesolutions.com |
| Zip | 98,021 |